Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | Director | September 15, 2025 | September 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date September 15, 2025 · Filed September 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 458,573 |
Reported balance
After 2025-09-15 transaction · row 1
1 source rowRow 1 · 2025-09-15 · Grant · Acquired 37,815 · Balance 458,573 F1: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025. |
| Options to purchase common stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.38 · Expires 2027-09-15 | Direct | 19,041 |
Reported balance
After 2025-09-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-09-15 · Grant · Acquired 19,041 · Balance 19,041 |
Filing footnotes · ownership attribution and instrument terms
F1: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2025 Filed Sep 17, 2025 20:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 19,041 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001493152-25-013888 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,041 Underlying: Common Stock · 19,041 shares Expires 2027-09-15 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 37,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-013888 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,573 F1 · shares: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 30,991 | $2.42 | $74,998.22 |
DisclosureSEC source: 0001641172-25-021933 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,758 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. Read SEC document |
| July 11, 2025 Filed Jul 23, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries I Warrant (right to buy) · Derivative | 30,624 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020694 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,624 shares Expires 2025-07-23 Read SEC document |
| July 11, 2025 Filed Jul 23, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherCommon Stock | 30,624 | $1.38 | $42,343.80 |
DisclosureSEC source: 0001641172-25-020694 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,767 Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001728 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,947 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 32,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001728 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,143 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| May 28, 2024 Filed Jun 25, 2024 22:14 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries H Warrant (right to buy) · Derivative | 30,625 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-24-025143 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,625 shares Expires 2024-06-26 Read SEC document |
| May 28, 2024 Filed Jun 25, 2024 22:14 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherCommon Stock | 30,625 | $1.38 | $42,345.19 |
DisclosureSEC source: 0001493152-24-025143 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,652 Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:53 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 11,098 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001493152-24-003778 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,111 Underlying: Common Stock · 11,098 shares Expires 2034-01-23 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:53 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 29,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003778 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,075 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 02, 2024 Filed Jan 11, 2024 21:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 3,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-002064 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,043 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 2,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-035647 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,860 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 3,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-023437 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,246 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 49,750 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001493152-23-018334 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,013 Underlying: Common Stock · 49,750 shares Expires 2033-05-17 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 149,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-018334 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,850 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries K Warrants to purchase Common Stock · Derivative | 30,624 | $1.63 Strike: $1.38 | $49,999.80 |
DisclosureSEC source: 0001493152-23-017791 · ownership.xml · derivative · entry 5 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,624 Underlying: Common Stock · 30,624 shares Expires not disclosed F9 · shares: The aggregate number of warrants reported in this row consists of 30,624 Series K Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F10 · derivative.expiration_date: The Series K Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the end of the fourth fiscal quarter after the fiscal quarter in which the first commercial sales of the CGuard Carotid Stent System in the United States begin. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries J Warrants to purchase Common Stock · Derivative | 30,625 | $1.63 Strike: $1.38 | $50,001.44 |
DisclosureSEC source: 0001493152-23-017791 · ownership.xml · derivative · entry 4 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,625 Underlying: Common Stock · 30,625 shares Expires not disclosed F7 · shares: The aggregate number of warrants reported in this row consists of 30,625 Series J Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F8 · derivative.expiration_date: The Series J Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's announcement of receipt of FDA approval for the SwitchGuard transcarotid system and CGuard Prime 80 cm. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries I Warrants to purchase Common Stock · Derivative | 30,624 | $1.63 Strike: $1.38 | $49,999.80 |
DisclosureSEC source: 0001493152-23-017791 · ownership.xml · derivative · entry 3 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,624 Underlying: Common Stock · 30,624 shares Expires not disclosed F5 · shares: The aggregate number of warrants reported in this row consists of 30,624 Series I Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F6 · derivative.expiration_date: The Series I Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's announcement of receipt of Premarket Approval (PMA) from the Food and Drug Administration ("FDA") for the CGuard Prime Carotid Stent System (135 cm). Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries H Warrants to purchase Common Stock · Derivative | 30,625 | $1.63 Strike: $1.38 | $50,001.44 |
DisclosureSEC source: 0001493152-23-017791 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,625 Underlying: Common Stock · 30,625 shares Expires not disclosed F3 · shares: The aggregate number of warrants reported in this row consists of 30,625 Series H Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F4 · derivative.expiration_date: The Series H Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's public release of primary and secondary end points related to one year follow up study results from the Company's C-Guardians pivotal trial. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 61,249 | $1.63 | $100,001.24 |
DisclosureSEC source: 0001493152-23-017791 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,590 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on May 12, 2023 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 7,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-010854 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,341 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended March 31, 2023. Read SEC document |
| October 13, 2021 Filed Oct 14, 2021 21:03 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 5,749 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001493152-21-025456 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,749 Underlying: Common Stock · 5,749 shares Expires 2031-10-13 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. Read SEC document |
| October 13, 2021 Filed Oct 14, 2021 21:03 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 17,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-025456 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,355 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseWarrants · Derivative | 60,480 | $0.62 Strike: $0.68 | $37,497.60 |
DisclosureSEC source: 0001493152-21-003208 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,480 Underlying: Common Stock · 60,480 shares Expires 2026-02-08 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit. F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 120,960 | $0.62 | $74,995.20 |
DisclosureSEC source: 0001493152-21-003208 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,593 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit. F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 120,960 shares of common stock and warrants to purchase 60,480 shares of common stock together, as part of 120,960 units, at a purchase price of $0.62 per unit. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:58 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 52,678 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001493152-20-017127 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,686 Underlying: Common Stock · 52,678 shares Expires 2030-08-31 F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:58 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 158,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-017127 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,633 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. F2 · balance_after: Consists of (i) an aggregate of 160,633 shares of common stock represented by restricted stock, which have vested or vest over time, subject to the Reporting Person's continued service, and (ii) 50,000 shares of common stock. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 15:59 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 50,000 | $0.42 | $20,750.00 |
DisclosureSEC source: 0001493152-20-010629 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,600 F1 · balance_after: 2,600 of these shares of common stock represent an award of restricted stock units ("RSUs"), which was previously reported by the Reporting Person, as 130,000 shares/RSUs, but which has been reduced to 2,600 RSUs due to a reverse split of the Issuer's common stock. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-001461 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 11:10 UTC | InspireMD, Inc. NSPR · Entity 7318 | SaleCommon Stock | 8 | $0.21 | $1.68 |
DisclosureSEC source: 0001493152-18-016696 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 14:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 2,500 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001493152-16-015741 · form4.xml · derivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2026-12-07 F1 · derivative.exercise_date: The options vest in three equal annual installments, with 1/3 becoming exercisable on each of December 7, 2017, December 7, 2018 and December 7, 2019, subject to Mr. Kester's continued service. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 16:07 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001493152-16-013190 · form4.xml · derivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2026-09-06 F1 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments, with 1/3 of the options (rounded down for fractional shares) becoming exercisable on September 6, 2017, an additional 1/3 of the options (rounded down for fractional shares) becoming exercisable on September 6, 2018, and the remaining options becoming exercisable on September 6, 2019, provided that the options vest in full and become exercisable immediately on such date that the Reporting Person is not re-elected as a director at the Issuer's 2017 annual meeting of stockholders or such date that the Reporting Person is not re-nominated as a director for the Issuer's 2017 annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.